RebrAIn
PrivateLast Round
Seed
Mar 18, 2024
Total Funding Raised
$4.4M
Company Overview
RebrAIn is a medical technology company that provides a precise targeting technology for helping with surgical treatments of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RebrAIn Comparables
Compare RebrAIn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniscient Neurotechnology | 77% | |
| Augmedit | 75% | |
| Zeta Surgical | 75% | |
RebrAIn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2024 | ||||
| Pre Seed | Apr 1, 2020 |
RebrAIn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nouvelle-Aquitaine Co-investissement | Seed |
| Karista | Seed |
| Aquitaine Science Transfert | Pre Seed, Seed |
RebrAIn Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RebrAIn's valuation, stock price, and market status.